Poly(ethylene glycol) diacrylate, MW 35,000

Poly(ethylene glycol) diacrylate, MW 35,000 - Polysciences
Poly(ethylene glycol) diacrylate, MW 35,000 - Polysciences

Product Number:

CAS #

CAS #                 Product #

    26423
    26570-48-9

Size

Price

$137.00

Quantity

Bulk Request

Request a Bulk Quote 

Product Specifications
Linear Formula
    C3H3O(OCH2CH2)nC3H3O2
Appearance
    White to yellow to tan solid
Safety Data Sheet (SDS)
Handling
    Gloves & fume hood
Storage
    Store at 4°C
Hazards
    Irritant, skin sensitizer
Related Documents

    Spec_Sheet_26423

Related Documents

    1. Vila, A., Torras, N., Castaño, A. G., García-Díaz, M., Comelles, J., Pérez-Berezo, T., ... & Martínez, E. (2020). Hydrogel co-networks of gelatine methacrylate and poly (ethylene glycol) diacrylate sustain 3D functional in vitro models of intestinal mucosa. Biofabrication, 12(2), 025008.2. Valentin, T. M., DuBois, E. M., Machnicki, C. E., Bhaskar, D., Cui, F. R., & Wong, I. Y. (2019). 3D printed self-adhesive PEGDA–PAA hydrogels as modular components for soft actuators and microfluidics. Polymer Chemistry, 10(16), 2015-2028.3. Hoffman, A. S. Hydrogels for biomedical applications. Advanced Drug Delivery Reviews 64, 18–23 (2012). doi:10.1016/j.addr.2012.09.0104. Hoare, T. R. & Kohane, D. S. Hydrogels in drug delivery: Progress and challenges. Polymer 49, 1993–2007 (2008). doi:10.1016/j.polymer.2008.01.0275. Nishi, S., Nakayama, Y., Hashimoto, N. & Matsuda, T. Basic fibroblast growth factor impregnated hydrogel microspheres for embolization of cerebral arteriovenous malformations. ASAIO journal (American Society for Artificial Internal Organs : 1992) 44, M405–10

Product Description

Poly(ethylene glycol) diacrylate, MW 35,000 (PEGDA 35K)

Poly(ethylene glycol) diacrylate (PEGDA 35K) is a multifunctional PEG-based macromer used in advanced materials synthesis, hydrogel formation, and polymer network research. It features a linear poly(ethylene glycol) backbone terminated with acrylate groups, which enables crosslinking through free-radical polymerization under appropriate initiation conditions.

Relative to lower molecular weight PEGDA grades, PEGDA 35K has longer chains between reactive end groups and can yield networks with lower crosslink density. In many formulations, this can translate to crosslinked materials with increased flexibility, higher swelling capacity, and mechanical properties that can be tuned through macromer concentration and crosslinking conditions.

PEGDA-based networks are widely investigated as hydrogels and are frequently evaluated as carrier matrices in drug delivery and biomedical materials research. Additional areas of use include polymerizable adhesives, coatings, sealants, microfluidic device fabrication, and photopolymer-based synthesis where controlled network formation and uniformity are important.


Key Properties

  • Chemical type: Poly(ethylene glycol) diacrylate
  • Molecular weight: 35,000 g/mol
  • Functional groups: Terminal acrylates
  • Polymerization mechanism: Free-radical crosslinking
  • Hydrophilicity: High
  • Network characteristics: Flexible, lightly crosslinked hydrogels (formulation-dependent)
  • Typical use: Research and development applications

Applications

Hydrogel and Biomaterials Research
PEGDA 35K is commonly used to form photopolymerized and chemically crosslinked hydrogels. Its higher molecular weight can support softer, more elastic networks with controllable permeability and swelling behavior, depending on formulation and curing conditions.

Drug Delivery and Biomedical Materials
Crosslinked PEGDA hydrogels are frequently investigated as carrier systems because their network structure can be tuned. Researchers often adjust properties by changing polymer concentration and crosslinking conditions.

Adhesives, Coatings, and Sealants
PEGDA 35K may be evaluated in polymerizable systems where flexibility, uniform crosslinking, and moisture compatibility are desired.

Microfluidics and Photopolymer Synthesis
The acrylate functionality of PEGDA supports photopatterning and microfabrication workflows, including microfluidic device research and light-initiated polymer network formation.


FAQs

Common questions about PEGDA 35K (Poly(ethylene glycol) diacrylate, MW 35,000).

  • What is PEGDA 35K used for?

    PEGDA 35K is commonly used to create crosslinked polymer networks, especially PEG-based hydrogels, for materials, biomaterials, and formulation research.

  • What does “diacrylate” mean in PEG diacrylate?

    “Diacrylate” indicates that the PEG chain is terminated with two acrylate functional groups. These end groups can undergo free-radical polymerization and enable network formation through crosslinking.

  • How does PEGDA molecular weight influence crosslink density?

    Higher molecular weight PEGDA typically places more chain length between reactive end groups, which can reduce crosslink density compared with lower molecular weight grades under similar formulation conditions. Actual outcomes depend on concentration, initiation system, and cure conditions.

  • Why might a researcher choose PEGDA 35K instead of a lower molecular weight PEGDA?

    PEGDA 35K is often selected when a formulation benefits from a more flexible network or higher swelling capacity, while still allowing network properties to be tuned by concentration and crosslinking conditions.

  • What factors most strongly affect PEGDA hydrogel properties?

    Common drivers include PEGDA concentration, initiation/curing conditions, and the presence of comonomers or additives. These variables influence crosslink density, swelling behavior, and mechanical response.

Poly(ethylene glycol) diacrylate, MW 35,000 - Polysciences
Poly(ethylene glycol) diacrylate, MW 35,000 - Polysciences
Product Specifications
Linear Formula
    C3H3O(OCH2CH2)nC3H3O2
Appearance
    White to yellow to tan solid
Safety Data Sheet (SDS)
Handling
    Gloves & fume hood
Storage
    Store at 4°C
Hazards
    Irritant, skin sensitizer
Related Documents

    Spec_Sheet_26423

References

    1. Vila, A., Torras, N., Castaño, A. G., García-Díaz, M., Comelles, J., Pérez-Berezo, T., ... & Martínez, E. (2020). Hydrogel co-networks of gelatine methacrylate and poly (ethylene glycol) diacrylate sustain 3D functional in vitro models of intestinal mucosa. Biofabrication, 12(2), 025008.2. Valentin, T. M., DuBois, E. M., Machnicki, C. E., Bhaskar, D., Cui, F. R., & Wong, I. Y. (2019). 3D printed self-adhesive PEGDA–PAA hydrogels as modular components for soft actuators and microfluidics. Polymer Chemistry, 10(16), 2015-2028.3. Hoffman, A. S. Hydrogels for biomedical applications. Advanced Drug Delivery Reviews 64, 18–23 (2012). doi:10.1016/j.addr.2012.09.0104. Hoare, T. R. & Kohane, D. S. Hydrogels in drug delivery: Progress and challenges. Polymer 49, 1993–2007 (2008). doi:10.1016/j.polymer.2008.01.0275. Nishi, S., Nakayama, Y., Hashimoto, N. & Matsuda, T. Basic fibroblast growth factor impregnated hydrogel microspheres for embolization of cerebral arteriovenous malformations. ASAIO journal (American Society for Artificial Internal Organs : 1992) 44, M405–10